INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
<h4>Importance</h4>Dementia is an "overdetermined" syndrome. Few individuals are demented by any single biomarker, while several may independently explain small fractions of dementia severity. It may be advantageous to identify individuals afflicted by a specific biomarker to g...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295386&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849717984559366144 |
|---|---|
| author | Donald R Royall Raymond F Palmer |
| author_facet | Donald R Royall Raymond F Palmer |
| author_sort | Donald R Royall |
| collection | DOAJ |
| description | <h4>Importance</h4>Dementia is an "overdetermined" syndrome. Few individuals are demented by any single biomarker, while several may independently explain small fractions of dementia severity. It may be advantageous to identify individuals afflicted by a specific biomarker to guide individualized treatment.<h4>Objective</h4>We aim to validate a psychometric classifier to identify persons adversely impacted by inflammation and replicate it in a second cohort.<h4>Design</h4>Secondary analyses of data collected by the Texas Alzheimer's Research and Care Consortium (TARCC) (N = 3497) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) (N = 1737).<h4>Setting</h4>Two large, well-characterized multi-center convenience samples.<h4>Participants</h4>Volunteers with normal cognition (NC), Mild Cognitive Impairment (MCI) or clinical "Alzheimer's Disease (AD)".<h4>Exposure</h4>Participants were assigned to "Afflicted" or "Resilient" classes on the basis of a psychometric classifier derived by confirmatory factor analysis.<h4>Main outcome(s) and measure(s)</h4>The groups were contrasted on multiple assessments and biomarkers. The groups were also contrasted regarding 4-year prospective conversions to "AD" from non-demented baseline diagnoses (controls and MCI). The Afflicted groups were predicted to have adverse levels of inflammation-related blood-based biomarkers, greater dementia severity and greater risk of prospective conversion.<h4>Results</h4>In ADNI /plasma, 47.1% of subjects were assigned to the Afflicted class. 44.6% of TARCC's subjects were afflicted, 49.5% of non-Hispanic Whites (NHW) and 37.2% of Mexican Americans (MA). There was greater dementia severity in the Afflicted class [by ANOVA: ADNI /F(1) = 686.99, p <0.001; TARCC /F(1) = 1544.01, p <0.001]. "INFLAMMATION" factor composite scores were significantly higher (adverse) in Afflicted subjects [by ANOVA in ADNI /plasma F(1) = 1642.64, p <0.001 and in TARCC /serum F(1) = 3059.96, p <0.001]. Afflicted cases were more likely to convert to AD in the next four years [by Cox's F, ADNI /plasma: F (252, 268) = 3.74 p < 0.001; TARCC /serum: F (160, 134) = 3.03, p < 0.001 (in TARCC's entire sample), F (110, 90) = 4.92, p <0.001 in NHW, and F(50, 44) = 2.13, p = 0.006 in MA]. The proportions converting were similar among afflicted NHW in both cohorts /biofluids but MA exhibited a lower risk (7% in TARCC /serum at 48 months).<h4>Conclusions and relevance</h4>Our inflammation-specific psychometric classifier selects individuals with pre-specified biomarker profiles and predicts conversion to "AD" across cohorts, biofluids, and ethnicities. This algorithm might be applied to any dementia-related biomarker making the psychometric estimation of individual biomarker effects feasible without biomarker assessment. Our approach also distinguishes individuals resilient to individual biomarker effects allowing for more accurate prediction and precision intervention. |
| format | Article |
| id | doaj-art-1886fa3becd54b86bba9077f4e1d2b6b |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-1886fa3becd54b86bba9077f4e1d2b6b2025-08-20T03:12:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01193e029538610.1371/journal.pone.0295386INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.Donald R RoyallRaymond F Palmer<h4>Importance</h4>Dementia is an "overdetermined" syndrome. Few individuals are demented by any single biomarker, while several may independently explain small fractions of dementia severity. It may be advantageous to identify individuals afflicted by a specific biomarker to guide individualized treatment.<h4>Objective</h4>We aim to validate a psychometric classifier to identify persons adversely impacted by inflammation and replicate it in a second cohort.<h4>Design</h4>Secondary analyses of data collected by the Texas Alzheimer's Research and Care Consortium (TARCC) (N = 3497) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) (N = 1737).<h4>Setting</h4>Two large, well-characterized multi-center convenience samples.<h4>Participants</h4>Volunteers with normal cognition (NC), Mild Cognitive Impairment (MCI) or clinical "Alzheimer's Disease (AD)".<h4>Exposure</h4>Participants were assigned to "Afflicted" or "Resilient" classes on the basis of a psychometric classifier derived by confirmatory factor analysis.<h4>Main outcome(s) and measure(s)</h4>The groups were contrasted on multiple assessments and biomarkers. The groups were also contrasted regarding 4-year prospective conversions to "AD" from non-demented baseline diagnoses (controls and MCI). The Afflicted groups were predicted to have adverse levels of inflammation-related blood-based biomarkers, greater dementia severity and greater risk of prospective conversion.<h4>Results</h4>In ADNI /plasma, 47.1% of subjects were assigned to the Afflicted class. 44.6% of TARCC's subjects were afflicted, 49.5% of non-Hispanic Whites (NHW) and 37.2% of Mexican Americans (MA). There was greater dementia severity in the Afflicted class [by ANOVA: ADNI /F(1) = 686.99, p <0.001; TARCC /F(1) = 1544.01, p <0.001]. "INFLAMMATION" factor composite scores were significantly higher (adverse) in Afflicted subjects [by ANOVA in ADNI /plasma F(1) = 1642.64, p <0.001 and in TARCC /serum F(1) = 3059.96, p <0.001]. Afflicted cases were more likely to convert to AD in the next four years [by Cox's F, ADNI /plasma: F (252, 268) = 3.74 p < 0.001; TARCC /serum: F (160, 134) = 3.03, p < 0.001 (in TARCC's entire sample), F (110, 90) = 4.92, p <0.001 in NHW, and F(50, 44) = 2.13, p = 0.006 in MA]. The proportions converting were similar among afflicted NHW in both cohorts /biofluids but MA exhibited a lower risk (7% in TARCC /serum at 48 months).<h4>Conclusions and relevance</h4>Our inflammation-specific psychometric classifier selects individuals with pre-specified biomarker profiles and predicts conversion to "AD" across cohorts, biofluids, and ethnicities. This algorithm might be applied to any dementia-related biomarker making the psychometric estimation of individual biomarker effects feasible without biomarker assessment. Our approach also distinguishes individuals resilient to individual biomarker effects allowing for more accurate prediction and precision intervention.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295386&type=printable |
| spellingShingle | Donald R Royall Raymond F Palmer INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. PLoS ONE |
| title | INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. |
| title_full | INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. |
| title_fullStr | INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. |
| title_full_unstemmed | INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. |
| title_short | INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach. |
| title_sort | inflammation s cognitive impact revealed by a novel line of identity approach |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295386&type=printable |
| work_keys_str_mv | AT donaldrroyall inflammationscognitiveimpactrevealedbyanovellineofidentityapproach AT raymondfpalmer inflammationscognitiveimpactrevealedbyanovellineofidentityapproach |